UV light signature in conjunctival melanoma; not only skin should be protected from solar radiation. by Rivolta, C. et al.
OPEN
CORRESPONDENCE
UV light signature in conjunctival melanoma; not only
skin should be protected from solar radiation
Journal of Human Genetics (2016) 61, 361–362; doi:10.1038/jhg.2015.152; published online 10 December 2015
Conjunctival melanoma represents 5% of
ocular melanomas. It is a highly recurrent
tumor leading to metastatic disease and death
at 10 years in 25–30% of patients.1 Recent
molecular investigations have indicated that
conjunctival and cutaneous melanomas may
share common features.2 For instance,
epidemiological studies have shown an
association between decreasing latitude
and increasing incidence of conjunctival
melanoma,3 suggesting that exposure to
sunlight has a role in its etiology.4 However,
strong molecular proof of such correlation
has not been established. We hereby report
the results of a genome-wide sequencing
effort of two conjunctival melanomas
documenting a strong ultraviolet (UV)
mutation signature.
We performed high-coverage whole-
genome sequencing (average read depth= 80x,
with 97.1% of the genome covered at least
40x) of two untreated perilimbic conjunctival
melanomas occurring in two Caucasian
women, aged 57 years (patient A) and 65
years (patient B) (Figures 1a and b). Somatic
mutations were ascertained by comparing the
DNA sequence of each tumor with their
respective germline matches (blood leukocyte
DNA). We identiﬁed a very high somatic
mutation load composed of more than 96 000
mutations in each tumor, resulting in an
average genome-wide mutational rate of 30
somatic mutations per million DNA bases.
On average, we detected 802 mutations in the
coding regions of genes. The ratio of
non-synonymous to synonymous variants
was 1.59:1, showing a prominence of passen-
ger mutations. Non-synonymous mutations
were composed mainly of missense (90%),
followed by nonsense changes (7%).
Moreover, detailed analysis of the mutation
spectrum uncovered a majority of cytosine to
thymine (C4T) transitions, occurring in 88
(patient A) and 83% (patient B) of the single-
nucleotide substitutions in these tumors
(Figure 1c). In addition, 80 and 100% of
these C4T changes, respectively, occurred at
the 3′ end of pyrimidine dinucleotides and
CC4TT changes represented 470% of all
tandem substitutions, showing the presence
of a typical UV mutational signature.5
Altogether, our molecular ﬁndings support
the occurrence of UV-induced DNA damage
in conjunctival melanoma indicating a link
between solar radiation and development of
this tumor. Awareness should therefore be
raised in the general population about the
beneﬁts of wearing UV-shielding eyeglasses,
in addition to skin sunscreens, when exposed
to sunlight.
Figure 1 (a) A partially pigmented melanoma is seen in the inferior perilimbic area with extension onto the cornea. The isolated inferior and temporal
pigmented areas were primary acquired melanosis (patient A). (b) A pigmented melanoma can be observed in the superior perilimbic area (patient B). (c)
Mutation spectrum of the two conjunctival melanomas (A: patient A, B: patient B), showing a clear ultraviolet-induced DNA damage signature. No somatic
mutations were detected in the melanoma-related genes BRAF and NRAS.
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